Qinglong Shang1, Haiping Wang, Yujia Song, Lanlan Wei, Catharina Lavebratt, Fengmin Zhang, Hongxi Gu. 1. Department of Microbiology, Harbin Medical University, Harbin, 150081, China; Heilongjiang key Laboratory of Infection and Immunity, Heilongjiang Province, China; Pathogenic-Biological key laboratory, Heilongjiang Higher Education Institutions, 150081, Harbin, China.
Abstract
OBJECTIVE: Serological studies on the relationship between adenovirus 36 (Ad36) and an increased risk of obesity development have shown conflicting results. We reviewed the published studies and carried out a meta-analysis to explore this relationship. METHODS: PubMed was searched until December 2012 for the relative references with sufficient information to estimate odds ratios (ORs) and 95% confidence intervals (CIs). A total of 11 case-control studies, including 2508 obese subjects and 3005 controls, were selected. RESULTS: Compared with nonobese controls, Ad36 infection significantly increased the obesity risk by a pooled OR of 1.60 (95% CI = 1.14-2.25; P < 0.01). Meta-regression showed that the types of subject and obesity assessments were potential risk factors. In the subgroup analysis, a significantly increased risk was found in children (OR = 1.95; 95% CI = 1.34-2.85; z = 3.45; P < 0.01) and those with an obesity assessment of BMI ≥ 30 kg/cm2 (OR = 1.89; 95% CI = 1.15-3.10; P < 0.05). CONCLUSIONS: Ad36 infection is associated with an increased risk of obesity development. To our knowledge, this is the first report to reveal the significant relationship in children with a serological data analysis.
OBJECTIVE: Serological studies on the relationship between adenovirus 36 (Ad36) and an increased risk of obesity development have shown conflicting results. We reviewed the published studies and carried out a meta-analysis to explore this relationship. METHODS: PubMed was searched until December 2012 for the relative references with sufficient information to estimate odds ratios (ORs) and 95% confidence intervals (CIs). A total of 11 case-control studies, including 2508 obese subjects and 3005 controls, were selected. RESULTS: Compared with nonobese controls, Ad36 infection significantly increased the obesity risk by a pooled OR of 1.60 (95% CI = 1.14-2.25; P < 0.01). Meta-regression showed that the types of subject and obesity assessments were potential risk factors. In the subgroup analysis, a significantly increased risk was found in children (OR = 1.95; 95% CI = 1.34-2.85; z = 3.45; P < 0.01) and those with an obesity assessment of BMI ≥ 30 kg/cm2 (OR = 1.89; 95% CI = 1.15-3.10; P < 0.05). CONCLUSIONS: Ad36 infection is associated with an increased risk of obesity development. To our knowledge, this is the first report to reveal the significant relationship in children with a serological data analysis.
Authors: Cynthia L Chappell; Mary Dickerson; R Sue Day; Olga Dubuisson; Nikhil V Dhurandhar Journal: J Virol Methods Date: 2016-11-05 Impact factor: 2.014
Authors: P K Berger; N K Pollock; E M Laing; S J Warden; K M Hill Gallant; D B Hausman; R A Tripp; L D McCabe; G P McCabe; C M Weaver; M Peacock; R D Lewis Journal: J Clin Endocrinol Metab Date: 2014-06-13 Impact factor: 5.958
Authors: Jameson D Voss; Daniel G Burnett; Cara H Olsen; Harry W Haverkos; Richard L Atkinson Journal: J Clin Endocrinol Metab Date: 2014-06-27 Impact factor: 5.958